Carboxymethyl Starch Films as Enteric Coatings: Processing and Mechanistic Insights.

Controlled release Drug delivery system(s) Formulation Gastrointestinal Infrared (IR) spectroscopy Materials science Responsive delivery system(s) Structure-properties correlations

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
09 Sep 2023
Historique:
received: 11 04 2023
revised: 02 09 2023
accepted: 04 09 2023
pubmed: 11 9 2023
medline: 11 9 2023
entrez: 10 9 2023
Statut: aheadofprint

Résumé

This study proposes the application of carboxymethyl starch derivatives as tablet coatings affording gastro-protection. Carboxymethyl starch (CMS) films were obtained by casting of aqueous filmogenic starch solutions with or without plasticizers and their structural organization was followed using Fourier transform infrared (FTIR), Thermogravimetric analysis (TGA), X-ray diffraction (XRD). Together with data from mechanical tests (tensile strength, elongation, Young's modulus) the results were used to select filmogenic formulations adapted for coatings of tablets. The behaviour of these films was evaluated in simulated gastric and intestinal fluids. The effect of plasticizers (glycerol and sorbitol) on the starch organization, on the rate of drying of the films and on the water vapor absorption was also analyzed. Various types of starch have been compared and the best results were found with high amylose starch (HAS) that was carboxymethylated in an aqueous phase to obtain carboxymethyl high amylose starch (CMHAS). The CMHAS coating solutions containing sorbitol or glycerol as plasticizers have been applied with an industrial pan coater and the final tablets exhibited a good gastro-resistance (up to 2h) in simulated gastric fluid followed by disintegration in simulated intestinal fluid (SIF). The CMHAS derivatives present a high potential as coatings for nutraceutical and pharmaceutical solid dosage forms.

Identifiants

pubmed: 37690776
pii: S0022-3549(23)00363-5
doi: 10.1016/j.xphs.2023.09.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Marc-André Labelle (MA)

Department of Chemistry, Research Chair on Enteric Dysfunctions 'Allerdys', CERMO-FC Center, Université du Québec à Montréal, C.P. 8888, Montreal, Quebec, H3C 3P8, Canada.

Pompilia Ispas-Szabo (P)

Department of Chemistry, Research Chair on Enteric Dysfunctions 'Allerdys', CERMO-FC Center, Université du Québec à Montréal, C.P. 8888, Montreal, Quebec, H3C 3P8, Canada. Electronic address: ispas-szabo.pompilia@uqam.ca.

Florent Vilotte (F)

Colorcon USA, Canada Branch, 3550 Rue Ashby, Saint-Laurent, Quebec, H4R 2C1, Canada.

Mircea Alexandru Mateescu (MA)

Department of Chemistry, Research Chair on Enteric Dysfunctions 'Allerdys', CERMO-FC Center, Université du Québec à Montréal, C.P. 8888, Montreal, Quebec, H3C 3P8, Canada. Electronic address: mateescu.m-alexandru@uqam.ca.

Classifications MeSH